BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2026 6:51:59 AM | Browse: 0 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 125392
Country China
Received
2026-07-07 07:08
Peer-Review Started
2026-07-07 07:08
First Decision by Editorial Office Director
Return for Revision
2026-08-15 16:02
Revised
2026-08-27 22:29
Publication Fee Transferred
Editorial Processing by Scientific Editor
2026-10-12 03:05
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2026-10-12 10:12
Articles in Press
2026-10-12 10:12
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-10-23 09:47
Publish the Manuscript Online
2026-11-19 06:51
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Correspondence
Article Title Letter to the editor: Causal and translational considerations for Xiangshaliujunzi decoction-mediated PANoptosis in 5-fluorouracil-resistant gastric cancer
Manuscript Source Unsolicited Manuscript
All Author List Yu-Yi Zhang, Yi-Ge Yu, Yan-Qi Dang and Dan Hu
ORCID
Author(s) ORCID Number
Yan-Qi Dang http://orcid.org/0000-0002-0316-7880
Dan Hu http://orcid.org/0000-0002-5331-3276
Funding Agency and Grant Number
Funding Agency Grant Number
the Science and Technology Development Fund of Shanghai Pudong New Area PKJ2024-Y19
the Investigator-Initiated Trial Program of Shanghai Pudong New Area Health Commission, the Cohort Study Program 2025-PWDL-03
the National Pilot Zone for Inheritance, Innovation and Development of Traditional Chinese Medicine in Pudong New Area PDZY-2026-0318
the Science and Technology Development Project of Shanghai University of Traditional Chinese Medicine 25KFL82
Corresponding Author Yan-Qi Dang, 7 LAB Joint Laboratory, Seventh People’s Hospital, Shanghai University of Traditional Chinese Medicine, No. 358 Datong Road, Pudong New Area, Shanghai 200137, China. yq_dang@shutcm.edu.cn
Key Words Gastric cancer; 5-fluorouracil resistance; PANoptosis; Xiangshaliujunzi decoction; Drug synergy; Translational validation
Core Tip Gao et al reported that Xiangshaliujunzi decoction may overcome 5-fluorouracil resistance in gastric cancer through the miR-200a-3p/ZEB1/IRF1 axis and PANoptosis-associated signaling. This letter focuses on three evidentiary levels: Mechanistic causality, pharmacological interaction, and clinical relevance. We propose pathway-specific genetic validation, standardized drug exposure with quantitative combination analysis, preparation-level characterization, and independent clinical validation. These approaches may help determine whether the proposed molecular axis represents a therapeutically actionable mechanism rather than an associated molecular signature.
Publish Date 2026-11-19 06:51
Citation

Zhang YY, Yu YG, Dang YQ, Hu D. Letter to the editor: Causal and translational considerations for Xiangshaliujunzi decoction-mediated PANoptosis in 5-fluorouracil-resistant gastric cancer. World J Gastrointest Oncol 2026; 18(12): 125392

URL https://www.wjgnet.com/1948-5204/full/v18/i12/125392.htm
DOI https://doi.org/10.4251/wjgo.125392
Full Article (PDF) WJGO-18-125392-with-cover.pdf